Maddern XJ, Walker LC, Campbell EJ, Arunogiri S, Haber PS, Morley K, Manning V, Millan EZ, McNally GP, Lubman DI, Lawrence AJ. Can we enhance the clinical efficacy of cognitive and psychological approaches to treat substance use disorders through understanding their neurobiological mechanisms? Neurosci Biobehav Rev. 2022 Nov;142:104899. doi: 10.1016/j.neubiorev.2022.104899. Epub 2022 Sep 29. PMID: 36183863
Whitfield JB, Morgan TR, Seth D. Reply to: "External validation of a genetic risk score that predicts development of alcohol-related cirrhosis". J Hepatol. 2022 Dec;77(6):1721-1722. doi: 10.1016/j.jhep.2022.08.024. Epub 2022 Aug 31. PMID: 36055430.
Moensted ML, Buus N, Day CA. Examining Relational Dimensions of Service Encounters for Disadvantaged People Who Use Drugs. J Addict Nurs. 2022 Jul-Sep 01;33(3):159-167. doi: 10.1097/JAN.0000000000000479. PMID: 36041158.
Coupland H, Day C, Haber P et al. Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study. Drug and Alcohol Review (March 2022), 41, 706–714
Liu K, Terry Y, Masson S, Fateen W, Schwantes-An T-H, McCaughan GW, Aithal G, Seth D. Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol-related cirrhosis patients. Liver Cancer International 2022, 3: 99-104.
Whitfield JB, Seth D, Morgan TR. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank. Alcohol Clin Exp Res 2022, 46(12):2245-2257. DOI: 10.1111/acer.14968.
Whitfield JB, Schwantes-An T-H, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet J-M, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Mullhaupt B, Nagy L, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trepo E, Morgan TR, Seth D: A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatology 2022, 76(2):275-82.
Isbister GK, Jenkins S, Noutsos T, Isoardi KZ, Soderstrom J, Buckley NA. The diagnostic value of D-Dimer in Australian snake envenoming (ASP-29). Medical Journal of Australia 2022;217(4):203-7. doi: 10.5694/mja2.51589.
Noghrehchi F, Raubenheimer J, Dawson AH Buckley NA. Role of age-sex as underlying risk factors for death in acute pesticide self-poisoning: A prospective cohort study. Clinical Toxicology 2022;60(2):184-190. doi: 10.1080/15563650.2021.1921186
Wijerathna TM, Buckley NA, Gawarammana IB, Raubenheimer J, Shahmy S, Chathuranga U, Palangasinghe C, Shihana F, Dissanayake AMSDM, Mohamed F. Epidemiology and renal injury following Methyl-4-chlorophenoxyacetic acid (MCPA) poisoning. Scientific Reports 2022; 12:21940. doi: 10.1038/s41598-022-25313-z.
Chitty KM, Raubenheimer J, Kirby K, Cairns R, Buckley NA. Deliberate self-poisoning in Australian adolescents is increased on school days. Journal of Psychiatric Research 2022; 148: 103–109. doi: 10.1016/j.jpsychires.2022.01.045
Perananthan V, Wijerathna TM, Mohamed F, Gawarammana IB, Dawson AH, Buckley NA. Circulating intestinal fatty acid binding protein and gastrointestinal toxicity in Russell’s Viper envenomation. Clinical Toxicology 2022;60(3):311-318. doi:10.1080/15563650.2021.1965160.
Schaffer A, Bruno C, Buckley NA, Cairns R, Litchfield M, Paget S, Zoega H, Nassar N, Pearson SA. Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children. Paediatric and Perinatal Epidemiology 2022; 36:726–737. doi:10.1111/ppe.12870.
Daniels B, Schaffer A, Buckley NA, Bruno C, Jun M, Pearson SA, Zoega H. The impact of new prescribing restrictions for proton pump inhibitors in Australia: an evaluation using interrupted time series analysis. Pharmacoepidemiology and Drug Safety 2022;31(3):370-378. doi: 10.1002/pds.5395.
Nendick E, Mohamed F, Raubenheimer J, Gawarammana I, Buckley NA, Eddleston M. Acute Fungicide Self-Poisoning - A Prospective Case Series. Clinical Toxicology 2022;60(10):1106-12. doi: 10.1080/15563650.2022.2105710.
Dassanayake TL, Weerasinghe VS, Gawarammana I, Cooper P, Buckley NA. Changes of attention-related brain activity over 6 months after acute organophosphate pesticide poisoning: a prospective follow-up study. Clinical Toxicology 2022; 60(5): 576-584. doi: 10.1080/15563650.2021.2010742.
Schaffer AL, Brett J, Buckley NA, Pearson SA. Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use. Pain 2022; 163: e614–e621. doi:10.1097/j.pain.0000000000002433.
Chan BS, Isbister GK, Chiew AL, Isoardi K, Buckley NA. Clinical Experience with Titrating Doses of Digoxin Antibodies in Acute Digoxin Poisoning (ATOM-6). Clinical Toxicology 2022; 60(4):433-439. doi: 10.1080/15563650.2021.1968422.
Chiew AL, Raubenheimer JE, Berling I, Buckley NA, Becker T, Chan B, Brett J. Just “nanging” around - nitrous oxide abuse. A retrospective case series and review of internet searches, social media posts and the coroner’s database. Internal Medicine Journal 2022;52: 1724–1732. doi: 10.1111/imj.15391
Pai K, Buckley NA, Isoardi KZ, Isbister GK, Becker T, Chiew AL, Cairns R, Brown J, Chan BS. Optimising Alkalinisation and its effect on QRS Narrowing in Tricyclic Antidepressant Poisoning. British Journal of Clinical Pharmacology 2022;88:723–733. doi: 10.1111/bcp.15008
Rambabu L, Mohamed F, Raubenheimer J, Roberts MS, Buckley NA, MacKenzie L, Gawarammana IB, Eddleston M. Acute phenthoate self-poisoning: a prospective case series. Clinical Toxicology 2022;60(2):214-220. doi: 10.1080/15563650.2021.1917596
Rahman S, Trussell A, Pearson SA, Buckley NA, Karanges EA, Cairns R, Litchfield M, Todd A, Gisev N. Trends in fentanyl utilisation and fatal overdose across Australia, 2003-2015. Drug and Alcohol Review 2022;41(2):435-443. doi:10.1111/dar.13391.
Mirabella J, Ravi D, Chiew A, Buckley NA, Chan BS. Prescribing Trend of Tapentadol in a Sydney Local Health District. British Journal of Clinical Pharmacology 2022; 88:3929–3935. doi: 10.1111/bcp.15448.
Chiew AL, Buckley NA. The Serotonin Toxidrome: shortfalls of current diagnostic criteria for related syndromes. Clinical Toxicology 2022;60(2):143-158. doi: 10.1080/15563650.2021.1993242.
Ling R, White B, Roberts J, Cretikos M, Howard MV, Haber PS, Lintzeris N, Reeves P, Dunlop AJ, Searles A. Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model. BMC Health Serv Res. 2022 Nov 8;22(1):1326. doi: 10.1186/s12913-022-08687-8.
Merrick TT, Louie E, Cleary M, Molloy L, Baillie A, Haber P, Morley KC. A systematic review of the perceptions and attitudes of mental health nurses towards alcohol and other drug use in mental health clients. Int J Ment Health Nurs. 2022 Dec;31(6):1373-1389. doi: 10.1111/inm.13043. Epub 2022 Jul 31. PMID: 35909095
Louie E, Giannopoulos V, Baillie A, Uribe G, Wood K, Teesson M, Haber PS, Morley KC. Relationship between clinician-level attributes and implementation outcomes from the Pathways to Comorbidity Care training program. BMC Med Educ. 2022 Aug 5;22(1):605. doi: 10.1186/s12909-022-03671-6. PMID: 35931994
Chitty KM, Cvejic RC, Heintze T, Srasuebkul P, Morley K, Dawson A, Carter G, Dinh M, Buckley NA, Trollor JN. The Association Between Problematic Use of Alcohol and Drugs and Repeat Self-Harm and Suicidal Ideation. Crisis. 2022 Sep 8. doi: 10.1027/0227-5910/a000880. Epub ahead of print. PMID: 36073254.
Louie E, Giannopoulos V, Uribe G, Wood K, Teesson M, Childs S, Baillie A, Haber PS, Morley KC. Geographical variation in implementation of the Pathways to Comorbidity Care program in Australian drug and alcohol services. JBI Evid Implement. 2022 Oct 5. doi: 10.1097/XEB.0000000000000344. Epub ahead of print. PMID: 36378096.
Uribe Guajardo MG, Baillie A, Louie E, Giannopoulos V, Wood K, Riordan B, Haber P, Morley K. The evaluation of the role of technology in the pathways to comorbidity care implementation project to improve management of comorbid substance use and mental disorders. J Multimorb Comorb. 2022 Apr doi: 10.1177/26335565221096977. PMID: 35586033;
Josifovski N, Shand F, Morley K, Chia J, Henshaw R, Petrie K, Reda B, Li E, Theobald A, Onie S, Torok M, Berrouiguet S, Batterham PJ, Carter G, Haber P, Christensen H, Larsen ME. A pilot study of a text message and online brief contact intervention following self-harm or a suicide attempt: A mixed methods evaluation. Gen Hosp Psychiatry. 2022 May-Jun;76:1-2. doi: 10.1016/j.genhosppsych.2022.03.002. Epub 2022 Mar 11. PMID: 35303519.
Morley KC, Louie E, Hurzeler T, Baillie A, Dore G, Phung N, Haber PS. Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence. Front Glob Womens Health. 2022 Mar 29;3:807269. doi: 10.3389/fgwh.2022.807269. PMID: 35425938
Louie E, Giannopoulos V, Baillie A, Uribe G, Wood K, Teesson M, Childs S, Rogers D, Haber PS, Morley KC. Barriers and Facilitators to the Implementation of the Pathways to Comorbidity Care (PCC) Training Package for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings Frontiers in Health Services: Implementation Science, 17(4):304-312
Morley KC, Logge WB, Riordan BC, Brannon S, Haber PS, Conner TS. Daily experiences of hangover severity and food consumption in young adults. Br J Health Psychol. 2022 May;27(2):468-483. doi: 10.1111/bjhp.12555. Epub 2021 Aug. PMID: 34431182
Logge W, Baillie A, Haber P, Towers E, Riordan BC, Morley K. Sex differences in the interrelations between stress, craving and alcohol consumption across individuals and time during baclofen treatment for alcohol dependence. Addict Behav. 2023 Jan;136:107462. doi: 10.1016/j.addbeh.2022.107462. Epub 2022 Aug 11. PMID: 36084413.
Purcell-Khodr G, Webster E, Harrison K, Dawson A, Lee K, Conigrave K. The Importance of Culture in Alcohol Care: Listening to First Nations staff in Australian Aboriginal Community Controlled Health Services. The International Indigenous Policy Journal. 2022;13(3):1-29.
Lee K, Bullen LM, Zheng C, Dawson A, Munro A, Conigrave KM. Beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal clients to involuntary drug and alcohol treatment: A qualitative study. Drug and Alcohol Review. 2023;42(1):169-80. (First published 04 October 2022)
Stearne AE, Lee K, Allsop S, Shakeshaft A, Wright M. Self-determination by First Nations Australians in alcohol policy: lessons from Mbantua/Alice Springs (Northern Territory, Australia). International Journal of Drug Policy. 2022;108:103822.
Lee K, Wilson S, Stearne AE, Hayman N, Conigrave JH, Doyle M, Bullen L, Weatherall TJ, James D, Reynolds T, Perry J. Walking side‐by‐side: Supporting Aboriginal and Torres Strait Islander Australians to lead the way in alcohol research. Drug and Alcohol Review. 2023;42(2):241-7. (first published 04 August 2022)
Conigrave JH, Lee K, Haber PS, Vnuk J, Doyle MF, Conigrave KM. More than three times as many Indigenous Australian clients at risk from drinking could be supported if clinicians used AUDIT-C instead of unstructured assessments. Addiction Science & Clinical Practice. 2022;17(1):23.
Dzidowska M, Raubenheimer JE, Dobbins TA, Lee K, Hayman N, Vnuk J, Haber P, Conigrave KM. Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial. Addiction science & clinical practice. 2022;17(1):1-2.
Routledge K, Snijder M, Newton N, Ward J, Doyle M, Chapman C, Champion KE, Lees B, Bock SG, Wang Y, Olthuis PW. Acceptability and feasibility of Strong & Deadly Futures, a culturally-inclusive alcohol and drug prevention program for Aboriginal and/or Torres Strait Islander secondary students. SSM-Mental Health. 2022;2:100073.
Stearne AE, Lee K, Allsop S, Shakeshaft A, Wright M. First Nations Australians’ self-determination in health and alcohol policy development: a Delphi study. Health Research Policy and Systems. 2022;20(1):12.
Stapinski L, Routledge K, Snijder M, Doyle M, Champion K, Chapman C, Ward J, Baumgart A, Lee K, Teesson M, Newton N. A web-based alcohol and other drug prevention program (Strong & Deadly Futures) for Aboriginal and Torres Strait Islander school students: protocol for a cluster randomized controlled trial. JMIR Research Protocols. 2022;11(1):e34530.
Conigrave JH, Wilson S, Conigrave KM, Chikritzhs T, Hayman N, Dawson A, Ali R, Perry J, Fitts MS, Degenhardt L, Doyle M, Lee K. ‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians. Addiction Science & Clinical Practice. 2022;17(1):1-1.
Gendera S, Treloar C, Reilly R, Conigrave KM, Butt J, Roe Y, Ward J. ‘Even though you hate everything that's going on, you know they are safer at home’: The role of Aboriginal and Torres Strait Islander families in methamphetamine use harm reduction and their own support needs. Drug and Alcohol Review. 2022;41(6):1428-39.
Noroozi A, Conigrave KM, Mirrahimi B, Bastani P, Charkhgard N, Salehi M, Narenjiha H, Vaziri A, Kebriaeezadeh A. Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran. Drug and Alcohol Review. 2022;41(2):419-29.
Doyle MF, Guthrie J, Butler T, Shakeshaft A, Conigrave K, Williams M. Opportunities for intervention for alcohol and other drug use problems for men before prison: A qualitative study. Health Promotion Journal of Australia. 2022.
Al Ansari M, Dawson A, Conigrave K. Alcohol among young people in Iraq: a systematic scoping review. Discover Psychology. 2022;2(1):16.
Conigrave JH, Conigrave KM, Wilson S, Lee K. Indigenous Australian drinking risk: Comparing risk categorisations based on recall of recent drinking occasions to AUDIT‐C screening in a representative sample. Drug and Alcohol Review. 2022;41(3):616-24.
Doyle MF, Williams M, Butler T, Shakeshaft A, Conigrave K, Guthrie J. Perspectives of prisoners on alcohol and other drug group treatment approaches. International Journal of Prisoner Health. 2022;18(1):55-65.
Al Ansari M, Dawson A, Room R, Abdulzahra M, Conigrave KM. Alcohol and University Students in Iraq: Attitudes, Availability, and Use. Journal of Muslim Mental Health. 2022;16(2).
Zheng C, Conigrave JH, Conigrave KM, Wilson S, Perry J, Chikritzhs TN, Fitts MS, Lee K. Patterns of drinking in Aboriginal and Torres Strait Islander peoples as self‐reported on the Grog Survey App: a representative urban and remote sample. Drug and Alcohol Review. 2022;41(1):114-24.
Weatherall TJ, Conigrave JH, Conigrave KM, Perry J, Wilson S, Room R, Fitts MS, Hayman N, Lee K. Prevalence and correlates of alcohol dependence in an Australian Aboriginal and Torres Strait Islander representative sample: using the Grog Survey App. Drug and Alcohol Review. 2022;41(1):125-34.
Bradshaw EL, Conigrave JH, Steward BA, Ferber KA, Parker PD, Ryan RM. A meta-analysis of the dark side of the American dream: Evidence for the universal wellness costs of prioritizing extrinsic over intrinsic goals. Journal of Personality and Social Psychology. 2022.
James DB, Lee K, Dronavalli M, Courtney RJ, Conigrave KM, Conigrave JH, Shakeshaft A. Predictors of length of treatment, discharge reason, and re‐admission to Aboriginal alcohol and other drug residential rehabilitation services in New South Wales, Australia. Drug and Alcohol Review. 2022;41(3):603-15. doi: 10.1111/dar.13388. Epub 2021 Oct 13. PMID: 34644427.
Dunlop AJ, White B, Roberts J, Cretikos M, Attalla D, Ling R, Searles A, Mackson J, Doyle MF, McEntyre E, Attia J. Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Addiction. 2022;117(2):382-91.
Lee K, Wilson S, Stearne A, Hayman N, Conigrave JH, Doyle MF, Bullen L, Weatherall TJ, James Douglas B, Reynolds T, Perry J, Conigrave KM. Walking side-by-side: supporting Aboriginal and Torres Strait Islander Australians to lead the way in alcohol research. Drug Alcohol Rev. 2022;doi.org/10.1111/dar.13523
Doyle MF, Dsouza B, Conigrave KM. Perceived impacts of a prison-based drug treatment program on planning for release: A qualitative study. Drug and Alcohol Review. 2022; 41:S18.
Freeburn B, Loggins S, Lee K, Conigrave K. Coming of age: 21 years of providing opioid substitution treatment within an Aboriginal community-controlled primary health service. Drug Alcohol Rev. 2022;41(1):260-4.
Dzidowska M, Lee K, Conigrave JH, Dobbins TA, Hummerston B, Wilson S, Haber PS, Gray D, Conigrave KM. Support for Aboriginal health services in reducing harms from alcohol: 2-year service provision outcomes in a cluster randomized trial. Addiction [Internet]. 2022;117(3):796-803.
Watt J, Haber P, Conigrave K. How to Treat: Unhealthy alcohol use. Australian Doctor. 2022;13-20.
Qiang S, Mohamed F, Mackenzie L, Roberts MS. Rapid determination of polyethoxylated tallow amine surfactants in human plasma by LC-MSMS. Talanta. 2022 Nov 19;254:124115. doi: 10.1016/j.talanta.2022.124115. Epub ahead of print. PMID: 36481395.
Deuster E, Tomenson JA, Mohamed F, Gawarammana I, Buckley NA, Wilks MF, Eddleston M. Dose ingested, vomiting, and outcome in patients ingesting a standard paraquat 20SL formulation. Clinical Toxicology. 2022 Dec 21:1-10. doi: 10.1080/15563650.2022.2142601. Epub ahead of print. PMID: 36541442.
Dhanarisi J, Perera S, Wijertahna T, Gawarammana I, Eddleston M, Mohamed F. Relationship between alcohol co-ingestion and clinical outcome in pesticide self-poisoning: a systematic review and a meta-analysis. Alcohol and Alcoholism, 2022; agac045
Schölin L, Weerasinghe M, Agampodi S, Chathurange U, Rajapaksha S, Holloway A, Norrie J, Mohamed F, Eddleston M, Pearson M. (March 2022) Involvement of alcohol in injury cases in rural Sri Lanka: prevalence and associated factors among in-patients in three primary care hospitals. BMC Public Health, 22(1)
Egan L, Riordan B, Newling G, Uthurralt N., Day, CA. (2022) Sydney’s inner-west is brimming with micro-breweries, should we be worried and what does it mean for research and policy? Drug and Alcohol Review. DOI: 10.1111/dar.13611
Day CA, Salmon A, Jauncey M, Bartlett M, Roxburgh A. (2022) Twenty years at the Uniting Medically Supervised Injecting Centre, Sydney Australia: addressing the remaining questions. Medical Journal of Australia, 271(8): 385-387 DOI:10.5694/mja2.51716
Reid SE, Day CA, White N, Harrison, C, Haber PS, Bayram C. (2022) Patterns of opioid prescribing in Australian General Practice. BMC Primary Care; 23: 171. https://doi.org/10.1186/s12875-022-01783-y
Coupland H, Henderson C, Pritchard-Jones, J, Kao, S, Sheils S, Nagy R, O’Donnell M, Haber, PS, Day CA. (2022) “Setting foot in private spaces: Extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines. BMC Harm Reduction Journal; 19:56. doi.org/10.1186/s12954-022-00640-6
Uthurralt, N, McGlinn, A, O’Donnell, M, Haber, PS. Day, CA. (2022). The impact of 24-hour syringe dispensing machine on use of face-to-face needle and syringe program and targeted primary healthcare clinic for people who inject drugs. Australian and New Zealand Journal of Public Health, 46(4): 524-526. http://doi.org/10.1111/1753-6405.13267
Winter DT, Geiger B, Day, CA. (2022) A comment on participant reimbursement within Australian drug and alcohol research. Drug and Alcohol Review. 41: 1484-1486 https://doi.org/10.1111/dar.13452
Coupland H, Haber P, Day CA, Pritchard-Jones J, McKee K, George J, McCaughan G. (2022) “It’s another thing to deal with”: Resisting hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia. Drug and Alcohol Review. DOI: 10.1111/dar.13414
Logge WB, Morley KC, Haber PS. GABAB Receptors and Alcohol Use Disorders: Clinical Studies. Curr Top Behav Neurosci. 2022;52:195-212. doi:10.1007/7854_2020_182. PMID: 33580440.
Evans NT, Williams N, Perananthan V, Lugg W, Dawson AH, Osborn DA. Neonatal serotonin toxicity. J Paediatr Child Health. 2022 Jan;58(1):189-190. doi: 10.1111/jpc.15443. Epub 2021 Mar 16. PMID: 33724598
Fitts MS, Burchill R, Wilson S, Palk GR, Clough AR, Conigrave KM, Slade T, Shakeshaft A, Lee KSK. Drink driving among Aboriginal and Torres Strait Islander Australians: What has been done and where to next? Drug Alcohol Rev. 2022 Sep;41(6):1412-1417. doi: 10.1111/dar.13418. Epub 2021 Dec 19. PMID: 34927302
Smith JL, Soderstrom J, Dawson A, Alfred S, Greene S, Isoardi K, McCutcheon D, Oosthuizen F, Ezard N, Burcham J, Fatovich DM; EDNA Investigators. The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department. Emerg Med Australas. 2022 Feb;34(1):58-64. doi: 10.1111/1742-6723.13839. Epub 2021 Aug 12. PMID: 34382338.
Siefried KJ, Ezard N, Christmass M, Haber P, Ali R; NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group. A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia. Drug Alcohol Rev. 2022 Feb;41(2):309-319. doi: 10.1111/dar.13350. Epub 2021 Jul 8. PMID: 34237176
Sahinovic A, Irwin C, Doohan PT, Kevin RC, Cox AJ, Lau NS, Desbrow B, Johnson NA, Sabag A, Hislop M, Haber PS, McGregor IS, McCartney D. Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial. Sports Med Open. 2022 Mar 2;8(1):27. doi:10.1186/s40798-022-00417-y. PMID: 35235092; PMCID: PMC8891421.
Graham S, Blaxland M, Bolt R, Beadman M, Gardner K, Martin K, Doyle M, Beetson K, Murphy D, Bell S, Newman CE, Bryant J. Aboriginal peoples’ perspectives about COVID-19 vaccines and motivations to seek vaccination: a qualitative study. BMJ Glob Health. 2022 Jul;7(7):e008815. doi:10.1136/bmjgh-2022-008815. PMID: 35858705; PMCID: PMC9304971.
Nash E, Walker E, Watt J, Sannikova A, Dawson A, Anderson T, Sheather M, Jewitt J, Linnegar P, Hutchings O, Haber PS. Management of alcohol and other drug issues in Special Health Accommodation during the COVID-19 Delta variant outbreak in Sydney, 2021. Drug Alcohol Rev. 2022 Sep;41(6):1319-1321. doi:10.1111/dar.13506. Epub 2022 Jun 21. PMID: 35730108
Dawson A. Physostigmine should be used more readily for antimuscarinic toxicity: PRO. Br J Clin Pharmacol. 2022 Jan;88(1):58-60. doi:10.1111/bcp.15120. Epub 2021 Nov 16. PMID: 34705298
Chan BS, Sheppeard V, Dawson AH. E-cigarette or vaping product use-associated lung injury in an adolescent. Med J Aust. 2022 Apr 18;216(7):374.doi: 10.5694/mja2.51473. Epub 2022 Mar 24. PMID: 35324022
Graham S, Martin K, Beadman M, Doyle M, Bolt R. Our relationships, our values, our culture - Aboriginal young men's perspectives about sex, relationships and gender stereotypes in Australia. Cult Health Sex. 2023 Mar;25(3):304-319. doi: 10.1080/13691058.2022.2039776. Epub 2022 Feb 22. PMID: 35192437.
Isbister GK, Noutsos T, Jenkins S, Isoardi KZ, Soderstrom J, Buckley NA. D-dimer testing for early detection of venom-induced consumption coagulopathy after snakebite in Australia (ASP-29). Med J Aust. 2022 Aug 15;217(4):203-207. doi: 10.5694/mja2.51589. Epub 2022 Jun 7. PMID: 35670073.
Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1. PMID: 36453811
Rafizadeh A, Bhalla A, Sharma N, Kumar K, Zamani N, McDonald R, Roberts DM, Hassanian-Moghaddam H. Evaluating new simplified assays for harm reduction from methanol poisoning using chromotropic acid kits: An analytical study on Indian and Iranian alcoholic beverages. Front Public Health. 2022;10: 983663.
Ghannoum M, Roberts DM, Goldfarb DS, Heldrup J, Anseeuw K, Galvao TF, Nolin TD, Hoffman B, Lavergne V, Meyers P, Gosselin S, Botnaru T, Mardini K, Wood DM. Extracorporeal treatment for methotrexate poisoning: Systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Neph 2022; 17(4): 602-622
Bouchard J, Yates C, Calello DP, Gosselin S, Roberts DM, Lavergne V, Hoffman RS, Ostermann M, Peng A, Ghannoum M; EXTRIP Workgroup. Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. Am J Kidney Dis. 2022 Jan;79(1):88-104
Beaulieu J, Roberts DM, Gosselin S, Hoffman RS, Lavergne V, Hovda KE, Megarbane B, Lung D, Thanacoody R, Ghannoum M. Treating ethylene glycol poisoning with alcohol dehydrogenase inhibition, but without extracorporeal treatments: a systematic review. Clinical Toxicology (Phila) 2022; 60(7): 784-797
Roberts DM, Hoffman RS, Brent J, Lavergne V, Hovda KE, Porter WH, McMartin KE, Ghannoum M. The serum glycolate concentration: its prognostic value and its correlation to surrogate markers in ethylene glycol exposures. Clinical Toxicology (Phila) 2022; 60(7):798-807
Murnion BP, Roberts DM. Responding to the rising number of suicides using barbiturates. Med J Aust. 2022; 216(4): 187-188.
Jamshidi N, Dhaliwal N, Hearn D, McCalman C, Wenzel R, Koutsogiannis Z, Roberts DM. Life-threatening barium carbonate poisoning managed with intravenous potassium, continuous veno-venous haemodialysis and endoscopic removal of retained ceramic glazes. Clin Toxicol (Phila). 2022 Aug;60(8):974-978.
Hlusicka J, Sevela S, Smid V, Sestak V, Roberts DM. Methaemoglobinaemia and oesophageal burns after accidental ingestion of an alkyl nitrite. Clin Toxicol (Phila). 2022; 60(11): 1288-1290.
Research letters/case/other reports
Chiew AL, Buckley NA. Comment on “The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes”. Clinical Toxicology 2022;60(9):1081-2. doi: 10.1080/15563650.2022.2101472
Chan BS, Buckley NA. Comment on – clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning Clinical Toxicology 2022; 60(4):448. doi: 10.1080/15563650.2021.2013497
Tan H, Stathakis P, Varghese B, Buckley NA, Chiew AL. Delayed Acetaminophen Absorption resulting in Acute Liver Failure. Case reports in Critical Care 2022; 2, Article ID 3672248, 6 pages. doi: 10.1155/2022/3672248
Chan BS, Buckley NA. Authors' reply to comment on: clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. Clinical Toxicology (Phila). 2022 Apr;60(4):548. doi: 10.1080/15563650.2021.2013497.
Rosenbaum E, Bode MJF, Roberts DM. Death from severe, refractory methaemoglobinaemia. A case report to illustrate an increasingly frequent manifestation of deliberate self-poisoning. Emerg Med Austral 2022; 34(4): 654-655.
Bode MJF, Huber J, Roberts DM. Decision-making in suicide: when is the patient not for resuscitation? Emerg Med Austral 2022; 34(3): 473-474. doi: 10.1111/1742-6723.13977. [case report]
Freeburn B, Lee K, Conigrave K. Patients from Aboriginal and Torres Strait Islander communities. In: NSW Ministry of Health. Management of withdrawal from alcohol and other drugs: Clinical Guidance. Sydney: NSW Ministry of Health; 2022. p. 90-2. www.health.nsw.gov.au/aod/professionals/Publications/clinical-guidance-withdrawal-alcohol-and-other-drugs.pdf
Freeburn B, Lee K, Conigrave K. Patients from Aboriginal and Torres Strait Islander communities. In: NSW Ministry of Health, editor. Management of Withdrawal from Alcohol and Other Drugs: Handbook. Sydney, NSW: NSW Ministry of Health; 2022. p. 46-8. www.health.nsw.gov.au/aod/professionals/Publications/handbook%20managing%20withdrawal%20alcohol%20and%20other%20drugs.pdf